WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--As previously announced on Oct. 31, Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its 2011 full-year and fourth-quarter sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EST on Thursday, Feb. 2. During the call, Kenneth C. Frazier, chairman and chief executive officer; Adam H. Schechter, president, Global Human Health; and Peter N. Kellogg, executive vice president and chief financial officer, will provide an overview of Merck’s business and financial performance.
